12:00 AM
Mar 27, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

D02: Began Phase I/II trial

Matrix said the gene target is active during neonatal development and normally is not expressed during adult life but is expressed during cardiac hypertrophy.


Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >